Market Cap

RadNet, Inc. Market Capitalization:

$5.48 Billion

USD as of Jan. 1, 2026

business RadNet, Inc. Company Profile

RadNet, Inc. Main Stock Listing

NASDAQ: RDNT

Market Capitalization History of RadNet, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $222.61 B
Danaher $164.98 B
Siemens Healthineers AG $57.84 B
IDEXX Laboratories, Inc. $53.62 B
Lonza Group Ltd $47.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of RadNet, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $5.48 B 14.04%
Jan. 1, 2025 $4.81 B 104.61%
Jan. 1, 2024 $2.35 B 118.49%
Jan. 1, 2023 $1.08 B -25.09%
Jan. 1, 2022 $1.44 B 43.77%
Jan. 1, 2021 $998.6 M -20.65%
Jan. 1, 2020 $1.26 B 65.35%
Jan. 1, 2019 $761.0 M 34.48%
Jan. 1, 2018 $565.9 M 75.00%
Jan. 1, 2017 $323.4 M -3.01%
Jan. 1, 2016 $333.4 M -24.21%
Jan. 1, 2015 $439.9 M 317.46%
Jan. 1, 2014 $105.4 M -36.15%
Jan. 1, 2013 $165.0 M 17.93%
Jan. 1, 2012 $139.9 M -31.04%
Jan. 1, 2011 $202.9 M 65.45%
Jan. 1, 2010 $122.7 M -31.25%
Jan. 1, 2009 $178.4 M -64.48%
Jan. 1, 2008 $502.3 M 50.17%
Jan. 1, 2007 $334.5 M 782.35%
Jan. 1, 2006 $37.9 M -27.66%
Jan. 1, 2005 $52.4 M -33.80%
Jan. 1, 2004 $79.2 M 97.22%
Jan. 1, 2003 $40.1 M -67.86%
Jan. 1, 2002 $124.9 M 119.61%
Jan. 1, 2001 $56.9 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

RadNet, Inc. Categories

United States languages Healthcare languages Diagnostics & Research
United States Healthcare United States Diagnostics & Research

Stocks & Indices

RadNet, Inc. has the following listings and related stock indices.


Stock: NASDAQ: RDNT

Stock: FSX: PQIA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.